Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
18,610,820
-
Share change
-
-989,178
-
Total reported value
-
$401,651,185
-
Put/Call ratio
-
54%
-
Price per share
-
$21.61
-
Number of holders
-
94
-
Value change
-
-$20,554,255
-
Number of buys
-
47
-
Number of sells
-
46
Institutional Holders of ALBIREO PHARMA INC - COMMON STOCK (ALBO) as of Q4 2022
As of 31 Dec 2022,
ALBIREO PHARMA INC - COMMON STOCK (ALBO) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,610,820 shares.
The largest 10 holders included
FEDERATED HERMES, INC., PERCEPTIVE ADVISORS LLC, Deep Track Capital, LP, Chicago Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, ArrowMark Colorado Holdings LLC, GW&K Investment Management, LLC, and Decheng Capital Management III (Cayman), LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.